The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.
The latest news from CDMOs, CMOs, and suppliers featuring news from Albemarle Fine Chemistry Services and Particle Dynamics.
Chemicals/Chemical API Manufacturing
Albemarle Fine Chemistry Services Expands With New Operations Building
Albemarle...
Lonza and Chr. Hansen Holding, a bioscience company, have received approval from antitrust regulators needed to establish a 50/50 joint venture in the live biotherapeutic product market. The companies, which announced the JV earlier this year...
The latest news from CDMOs, CMOs, and suppliers, featuring news from SK, Lonza, Catalent, and Velesco Pharma.
Chemicals/Chemical API Manufacturing
SK Holdings To Launch CDMO Business With New Identity in January
SK Holdings, the holding company...
The latest news from CDMOs, CMOs, and suppliers featuring news from Schott, PCI Pharma Services, Ajinomoto Bio-Pharma Services, LBB Specialties, and Meggle.
Chemicals/Chemical API Manufacturing
Ajinomoto Bio-Pharma Services To Buy Out JV in...
The latest news from CDMOs, CMOs, and suppliers featuring news from WuXi Biologics and Berkshire Sterile Manufacturing.
Biologics Manufacturing
WuXi Biologics Provides Update on Global Mfg Expansions
In its first-half earnings release, WuXi...
The latest news from CDMOs, CMOs, and suppliers featuring news from Samsung BioLogics, Colorcon and Halix.
Biologics Manufacturing
Samsung BioLogics Advances Large-Scale Perfusion Technology for Commercial Biomanufacturing
Samsung...
The latest news from CDMOs, CMOs, and suppliers featuring news from Olon, Cambrex, Catalent, Lonza, IDT Biologika, and LSNE.
Chemicals/Chemical API Manufacturing
Olon Expands Microbial GMP Manufacturing Site in Italy
Olon, an active...
Cambrex, a contract manufacturer of small-molecule active pharmaceutical ingredients and drug products, has signed a definitive agreement to be acquired by an affiliate of the Permira Funds, a private equity firm, in a transaction valued at...
Fujifilm has completed its acquisition of Biogen’s large-scale biologics manufacturing site in Hillerød, Denmark, near Copenhagen, for approximately $890 million.
With the closing of this transaction, the Hillerød manufacturing site is the fourth...
The latest news from CDMOs, CMOs, and suppliers featuring news from Lonza, Flamma, Regis Technologies, Evotec, Fujifilm Irvine Scientific, GenScript Biotech, Catalent, GenScript Biotech, Wasdell and Marken.
Chemicals/Chemical API...
Lonza has entered into a binding contractual agreement for the purchase of a sterile drug-product fill–finish facility in Stein, Switzerland from Novartis. The sterile, multi-product facility currently serves as the Novartis Center of Excellence...
The latest news from CDMOs, CMOs, and suppliers featuring news from Seqens, Ampac, WuXi, and Catalent.
Chemicals/Chemical API Manufacturing
Seqens to Open New Innovation and Development Center
Seqens, a contract development and...
Kit Check, a provider of automated medication management solutions for hospitals, has announced it has been accepted into a pilot program by the US Food and Drug Administration Act for evaluating package-level tracing and verification technology in...
The latest news from CDMOs, CMOs, and suppliers featuring news from Lonza, Piramal Pharma Solutions, Tergus Pharma, LSNE, Aptar, and Rentschler Fill Solutions.
Chemicals/Chemical API Manufacturing
Lonza To Expand HPAPI Development and Mfg...
Bristol-Myers Squibb (BMS) and Catalent have announced that Catalent has agreed to purchase BMS’ oral solid, biologics, and sterile product manufacturing and packaging facility in Anagni, Italy.
The 19,300-square-meter Anagni plant has served as...
